Diabetes drug shows promise for safely treating, detecting Alzheimer's disease

(Boston University Medical Center) A new study has found treatment with the diabetes drug amylin (or pramlintide) safely improves learning and memory function in AD patients and reduces the AD pathology in their brains. The findings, which appear in the Journal Translational Research and Clinical Interventions, also may lead to the development of a blood test for AD.